Работы, цитирующие эту работу

Работ: 2

Работа: Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

1. Advancements in risk stratification and management strategies in primary cardiovascular prevention

   Fotios Barkas, Yusuf Ziya Şener, Pelin Golforoush +25

   Обзорная статьяLipoproteins and Cardiovascular HealthAtherosclerosis2024Цитирований: 0

   ABIABI:AkademIndex/openalex/2024.review-article.000004

2. Peptide drugs for obesity and type 2 diabetes mellitus: an overview of clinical trials

   Haniyeh Barzgar, Darmadi Darmadi, Jabbarova Nafisa +2

   Обзорная статьяDiabetes Treatment and ManagementClinica Chimica Acta2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.review-article.000250